FDA Inspection 1146373 — Mark A. Hernandez, M.D.

Mark A. Hernandez, M.D. — FEI 3017062031

The FDA completed an inspection of Mark A. Hernandez, M.D. on April 30, 2021 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 30, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)